MetaCap

Ernexa Therapeutics (ERNA) vs Lakewood-Amedex Biotherapeutics (LABT)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Ernexa Therapeutics is the larger company by market cap ($2.3 million vs $2.2 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ERNA-43.10%LABT-71.18%
+8%-37%-82%
Oct 7, 20261 yearNov 20, 2026
ERNA-43.33%LABT-68.69%
+4%-37%-78%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ERNA versus LABT key metrics
MetricERNALABT
Share price$1.36$0.2449
Market cap$2.30M$2.19M
1-day change-16.56%+15.03%
EPS (TTM)$-11.22$-5.57
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Net income (latest FY)$-14.08M—
52-week high$37.50$98.20
52-week low$1.35$0.17
Distance from 52-week high-96.37%-99.75%
Analyst consensusnonestrong_buy
Avg. price target upside+2105.88%+4799.96%
Average volume43.90K16.14M
Shares outstanding1.69M8.95M
Employees55
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Ernexa Therapeutics

ERNA stock →

Ernexa Therapeutics Inc., a preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of treatment of cancer and autoimmune disease. The company's lead product is ERNA-101, an allogenic pro-inflammatory cytokine (IL-7/IL-15) secreting iMSC for the treatment of ovarian cancer; and ERNA-201, an anti-inflammatory cytokine (IL-10) secreting iMSC for the treatment of rheumatoid arthritis.

Health Care · Biotechnology: Pharmaceutical Preparations · 5 employees

About Lakewood-Amedex Biotherapeutics

LABT stock →

Lakewood-Amedex Biotherapeutics, Inc. operates as a clinical-stage biotechnology company that develops antimicrobial products in the United States.

Health Care · Biotechnology: Pharmaceutical Preparations · 5 employees

ERNA vs LABT FAQ

Which is bigger, Ernexa Therapeutics or Lakewood-Amedex Biotherapeutics?

Ernexa Therapeutics (ERNA) is larger, with a market capitalization of $2.30M compared with $2.19M for Lakewood-Amedex Biotherapeutics (LABT).

Are Ernexa Therapeutics and Lakewood-Amedex Biotherapeutics in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons